Eli Lilly and Novo Nordisk agreed to discount their GLP-1 medications from $1350 per month to around $245 to $350 per month.

Trump administration drug deals link U.S. prices to global lows, aiming to cut costs via Pfizer, AstraZeneca, and TrumpRx in 2026.

I spent an afternoon with the Color Countess, who is helping people find their best selves, no needles or dieting required.

Those weight loss drugs that have been so out of reach for many, may soon be affordable, even if you don't have insurance.

People taking GLP-1 meds could see costs drop in 2026, thanks to a new federal deal with Eli Lilly and Novo Nordisk, the ...

Friday on the RealClearPolitics podcast, Tom Bevan, Carl Cannon, and Andrew Walworth discuss whether anyone is in a position ...

Republican Chairman Ron Johnson excoriated ranking member Richard Blumenthal in a sprawling rant that transformed the hearing ...

Eli Lilly and Company announced promising results for its next-generation weight-loss drug Thursday, with patients losing up ...

Novo Nordisk and Eli Lilly reached deals to lower GLP-1 drug costs for Medicare and Medicaid patients under Trump’s new ...

MAGA Representative Marjorie Taylor Greene is still one of the few GOP members to rebuke President Trump and his lies in any ...

Even after Trump’s new deal, obesity drugs are still too expensive.

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...